Vanguard Group’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$39.6M Buy
3,526,785
+101,571
+3% +$1.16M ﹤0.01% 2296
2025
Q3
$39.6M Sell
3,425,214
-1,039,682
-23% -$12.2M ﹤0.01% 2267
2025
Q2
$54.7M Sell
4,464,896
-883,401
-17% -$11.1M ﹤0.01% 2078
2025
Q1
$76.6M Buy
5,348,297
+8,519
+0.2% +$133K ﹤0.01% 1907
2024
Q4
$85M Buy
5,339,778
+19,476
+0.4% +$385K ﹤0.01% 1937
2024
Q3
$128M Buy
5,320,302
+50,166
+1% +$1.15M ﹤0.01% 1760
2024
Q2
$105M Sell
5,270,136
-129,042
-2% -$2.51M ﹤0.01% 1813
2024
Q1
$107M Sell
5,399,178
-18,774
-0.3% -$363K ﹤0.01% 1822
2023
Q4
$122M Sell
5,417,952
-56,456
-1% -$1.17M ﹤0.01% 1754
2023
Q3
$111M Buy
5,474,408
+2,086
+0% +$47.3K ﹤0.01% 1752
2023
Q2
$140M Sell
5,472,322
-57,808
-1% -$1.52M ﹤0.01% 1664
2023
Q1
$164M Buy
5,530,130
+30,130
+0.5% +$875K ﹤0.01% 1560
2022
Q4
$149M Buy
5,500,000
+114,922
+2% +$2.81M ﹤0.01% 1595
2022
Q3
$117M Buy
5,385,078
+8,478
+0.2% +$222K ﹤0.01% 1686
2022
Q2
$147M Buy
5,376,600
+42,268
+0.8% +$1.21M ﹤0.01% 1605
2022
Q1
$179M Buy
5,334,332
+112,546
+2% +$3.62M ﹤0.01% 1619
2021
Q4
$181M Buy
5,221,786
+97,668
+2% +$3.16M ﹤0.01% 1669
2021
Q3
$160M Buy
5,124,118
+27,870
+0.5% +$946K ﹤0.01% 1730
2021
Q2
$185M Buy
5,096,248
+611,984
+14% +$25.3M ﹤0.01% 1668
2021
Q1
$196M Buy
4,484,264
+146,351
+3% +$6.87M 0.01% 1589
2020
Q4
$199M Buy
4,337,913
+112,313
+3% +$4.67M 0.01% 1465
2020
Q3
$140M Sell
4,225,600
-257,528
-6% -$8.23M ﹤0.01% 1501
2020
Q2
$132M Sell
4,483,128
-131,917
-3% -$3.82M ﹤0.01% 1531
2020
Q1
$124M Buy
4,615,045
+74,783
+2% +$2.23M 0.01% 1399
2019
Q4
$153M Buy
4,540,262
+21,511
+0.5% +$779K 0.01% 1539
2019
Q3
$169M Buy
4,518,751
+14,912
+0.3% +$569K 0.01% 1434
2019
Q2
$196M Sell
4,503,839
-37,552
-0.8% -$1.61M 0.01% 1371
2019
Q1
$194M Buy
4,541,391
+58,384
+1% +$2.61M 0.01% 1364
2018
Q4
$201M Buy
4,483,007
+183,480
+4% +$9.61M 0.01% 1241
2018
Q3
$295M Buy
4,299,527
+124,452
+3% +$8.01M 0.01% 1129
2018
Q2
$239M Sell
4,175,075
-106,740
-2% -$5.64M 0.01% 1231
2018
Q1
$197M Sell
4,281,815
-31,613
-0.7% -$1.5M 0.01% 1300
2017
Q4
$199M Buy
4,313,428
+82,396
+2% +$3.79M 0.01% 1304
2017
Q3
$191M Buy
4,231,032
+5,037
+0.1% +$215K 0.01% 1296
2017
Q2
$166M Sell
4,225,995
-124,523
-3% -$4.71M 0.01% 1346
2017
Q1
$166M Buy
4,350,518
+196,367
+5% +$7.65M 0.01% 1345
2016
Q4
$154M Buy
4,154,151
+237,343
+6% +$8.48M 0.01% 1346
2016
Q3
$136M Buy
3,916,808
+445,203
+13% +$15.6M 0.01% 1384
2016
Q2
$113M Buy
3,471,605
+176,952
+5% +$5.42M 0.01% 1437
2016
Q1
$94.7M Buy
3,294,653
+93,860
+3% +$2.5M 0.01% 1521
2015
Q4
$107M Buy
3,200,793
+99,841
+3% +$3.1M 0.01% 1419
2015
Q3
$88.2M Buy
3,100,952
+47,110
+2% +$1.64M 0.01% 1520
2015
Q2
$124M Buy
3,053,842
+143,275
+5% +$6.43M 0.01% 1382
2015
Q1
$143M Buy
2,910,567
+50,664
+2% +$2.35M 0.01% 1250
2014
Q4
$130M Buy
+2,859,903
New +$112M 0.01% 1239

Other funds holding AVNS